Deals Rumor Mill: Allergan, Alstom, Seven Generations
Botox maker and takeover target Allergan Inc. is preparing to reject the $46 billion hostile bid jointly lobbed by rival Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman, the Financial...To view the full article, register now.
Already a subscriber? Click here to view full article